Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDBioRestorative Therapies, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.33 | -$0.19 | -$0.26 |
| Q2 2025 | 1 | -$0.25 | -$0.15 | -$0.20 |
| Q3 2025 | 1 | -$0.25 | -$0.15 | -$0.20 |
| Q4 2025 | 1 | -$0.26 | -$0.16 | -$0.21 |
| Q1 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q3 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q4 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q1 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q3 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q4 2027 | 0 | $0.00 | $0.00 | $0.00 |
BioRestorative Therapies, Inc. Earnings Date And Information
BioRestorative Therapies, Inc. last posted its earnings results on Wednesday, February 26th, 2025. The company reported $-0.375 earnings per share for the quarter, missing analysts' consensus estimates of $-0.34333 by $0.03167. The company had revenue of 233,600 for the quarter and had revenue of 145,800 for the year. BioRestorative Therapies, Inc. has generated $-2 earnings per share over the last year ($-2.47 diluted earnings per share) and currently has a price-to-earnings ratio of -2.11. BioRestorative Therapies, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 31st, 2025 based on prior year's report dates.
BioRestorative Therapies, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$0.35 | -$0.13 | 0.22 | $333,333 | $233,600 |
| 08/13/2024 | Q2 2024 | -$0.56 | -$0.50 | 0.06 | $10,000 | $89,100 |
| 06/11/2024 | Q1 2024 | -$0.51 | -$0.33 | 0.18 | N/A | $35,000 |
| 06/11/2024 | Q4 2023 | -$0.51 | $0.25 | 0.76 | N/A | $19,300 |
| 11/13/2023 | Q3 2023 | -$0.68 | -$0.02 | 0.66 | $30,000 | $30,700 |
| 08/11/2023 | Q2 2023 | -$1.56 | -$0.77 | 0.79 | $65,000 | $64,500 |
| 05/12/2023 | Q1 2023 | -$1.26 | -$1.51 | -0.25 | N/A | $31,300 |
| 03/24/2023 | Q4 2022 | N/A | -$1.04 | N/A | N/A | $3,700 |
| 11/14/2022 | Q3 2022 | -$0.49 | -$1.29 | -0.8 | N/A | $29,000 |
| 08/15/2022 | Q2 2022 | -$0.55 | -$1.30 | -0.75 | N/A | $71,100 |
| 05/13/2022 | Q1 2022 | N/A | -$1.30 | N/A | N/A | $16,000 |
| 03/30/2022 | Q4 2021 | -$0.54 | -$23.39 | -22.85 | N/A | $5,000 |
| 11/15/2021 | Q3 2021 | N/A | -$4.99 | N/A | $8,000 | $8,000 |
| 08/16/2021 | Q2 2021 | N/A | -$5.10 | N/A | N/A | $15,000 |
| 05/17/2021 | Q1 2021 | N/A | -$19.72 | N/A | N/A | $18,000 |
| 04/29/2021 | Q4 2020 | N/A | -$7.26 | N/A | N/A | $17,000 |
| 04/12/2021 | Q3 2020 | N/A | -$2.10 | N/A | N/A | $15,000 |
| 04/12/2021 | Q2 2020 | N/A | $7.21 | N/A | N/A | $19,000 |
| 03/29/2021 | Q1 2020 | N/A | -$18.94 | N/A | N/A | $26,000 |
| 03/17/2021 | Q4 2019 | N/A | -$3.89 | N/A | N/A | $32,000 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
BioRestorative Therapies, Inc. Earnings: FAQ's
BioRestorative Therapies, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 31st, 2025 based offlast year's report dates.
The conference call for BioRestorative Therapies, Inc.'s latest earnings report can be listened to online.
The conference call transcript for BioRestorative Therapies, Inc.'s latest earnings report can be read online.
BioRestorative Therapies, Inc. (:BRTX) has a recorded annual revenue of $145,800.
BioRestorative Therapies, Inc. (:BRTX) has a recorded net income of $-10,417,704.BioRestorative Therapies, Inc. has generated $-2.47 earnings per share over the last four quarters.
BioRestorative Therapies, Inc. (:BRTX) has a price-to-earnings ratio of -2.11 and price/earnings-to-growth ratio is 0.11.